Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-016987
Filing Date
2025-06-12
Accepted
2025-06-12 16:55:55
Documents
1
Period of Report
2025-06-10

Document Format Files

Seq Description Document Type Size
1 form4-06122025_080651.html 4  
1 form4-06122025_080651.xml 4 4105
  Complete submission text file 0001415889-25-016987.txt   5529
Mailing Address 712 FIFTH AVENUE 49TH FLOOR NEW YORK NY 10019
Business Address
WAGENHEIM PHILIP (Reporting) CIK: 0001405684 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39580 | Film No.: 251043658

Mailing Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011
Business Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011 610-321-3700
Immunome Inc. (Issuer) CIK: 0001472012 (see all company filings)

EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)